Suchen
Foxo Technologies Inc
FOXOZur Watchlist hinzufügen
0.092USD
0.0000.00%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
31.56KMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Foxo Technologies Inc Unternehmen
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Foxo Technologies Inc Informationen
BörsenkürzelFOXO
Name des UnternehmensFoxo Technologies Inc
IPO-datumDec 11, 2020
CEOMr. Seamus Lagan
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeDec 11
Addresse477 South Rosemary Avenue
StadtWEST PALM BEACH
BörseUS 'Other OTC' and Grey Market
LandUnited States of America
Postleitzahl33401
Telefon16128000059
Websitehttp://delwinds.com/
BörsenkürzelFOXO
IPO-datumDec 11, 2020
CEOMr. Seamus Lagan
Führungskräfte von Foxo Technologies Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.36%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.36%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Foxo Technologies Inc?
Die fünf größten Anteilseigner von Foxo Technologies Inc sind: Mr. Bret Barnes
Wie viele Institutionen halten Anteile an Foxo Technologies Inc (FOXO)?
Mit Stand vom 2026Q1 halten 29 Institutionen Anteile an Foxo Technologies Inc, mit einem Gesamtmarktwert von etwa 249.32M, was 6.78% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 249192775.00 gestiegen.